No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
722 |
4. Check minimum number of eventsNone |
722 |
5. Include endpointsNone |
722 |
6. Filter based on genotype QC (FinnGen only) |
722 |
Control definitions (FinnGen only)
- Control exclude
- L12_INFECT_SKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L08
- Name in latin
- Pyoderma
Similar endpoints
↥List of similar endpoints to
Pyoderma
based on the number of shared cases.
Similar with more cases:
- Other local infections of skin and subcutaneous tissue
- Infections of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7378 | 3141 | 4153 |
| Only index persons | 5683 | 2533 | 3150 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.12 |
| Only index persons | 0.11 | 0.09 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 39.59 | 39.40 | 39.51 |
| Only index persons | 37.57 | 38.25 | 37.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 722 | 373 | 349 |
| Unadjusted period prevalence (%) | 0.14 | 0.13 | 0.15 |
| Median age at first event (years) | 43.51 | 41.75 | 45.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 662
- Matched controls
- 6621
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L08.0
ICD-10 Finland
Pyoderma
1499.8
323.0
460
10
68600
ICD-8 Finland
Other local infections of skin and subcutaneous tissue, Pyoderma
+∞
170.3
156
*
6860A
ICD-9 Finland
Other local infections of skin and subcutaneous tissue, Pyoderma
+∞
53.9
51
*
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
18.6
44.4
69
41
A46
ICD-10 Finland
Erysipelas
4.6
40.8
162
439
J01FF01
ATC
clindamycin; systemic
3.3
38.7
255
1055
E0000UV
ATC
NA
2.9
35.8
339
1771
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.8
31.1
147
458
L20.0
ICD-10 Finland
Besnier prurigo
5.5
30.8
97
201
E000001
ATC
NA
3.1
29.4
202
832
D07AC01
ATC
betamethasone; topical
2.6
28.2
279
1435
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.2
26.7
167
638
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
14.4
24.8
42
31
D07AB08
ATC
desonide; topical
3.7
24.8
118
365
J01DB01
ATC
cefalexin; oral
2.9
24.6
563
4393
D07CC01
ATC
betamethasone and antibiotics; topical
3.4
23.7
129
442
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
23.5
124
415
S97
ICPC
Chronic ulcer skin
5.9
23.0
66
121
D07BC01
ATC
betamethasone and antiseptics; topical
3.4
22.2
120
405
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.5
21.9
111
359
D07AC13
ATC
mometasone; topical
2.4
21.0
226
1168
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.6
19.4
95
298
H02AB06
ATC
prednisolone; systemic
2.1
19.3
335
2149
L30.3
ICD-10 Finland
Infective dermatitis
6.6
19.2
50
81
D07AA02
ATC
hydrocortisone; topical
2.9
19.0
130
517
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
72.0
18.8
21
*
D07AD01
ATC
clobetasol; topical
2.8
18.7
134
546
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
12.3
18.5
33
28
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
18.1
223
1218
TQW80
NOMESCO Finland
Local dermatologic skincare
7.4
17.6
42
60
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
8.6
17.2
37
45
E000002
ATC
NA
3.1
17.1
104
380
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
12.5
17.0
30
25
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
3.2
16.7
94
326
J01DA01
ATC
[U] cefalexin; systemic
2.0
16.6
430
3162
D09AB01
ATC
zinc bandage without supplements; topical
9.1
16.4
34
39
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.3
15.9
86
290
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
8.1
15.8
35
45
XQ802
NOMESCO Finland
Epicutan test
5.6
15.7
46
87
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
15.7
297
1913
N05BB01
ATC
hydroxyzine; systemic
3.8
15.5
68
194
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.2
15.4
202
1120
E000003
ATC
NA
4.3
15.3
58
145
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.8
14.8
106
428
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.9
14.7
41
73
R06AE07
ATC
cetirizine; oral
1.9
14.7
303
2005
J01MA12
ATC
levofloxacin; systemic
2.3
14.2
143
697
J01MA02
ATC
ciprofloxacin; systemic
1.9
13.1
256
1639
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
12.7
85
329
-
ICD-10 Finland
NA
6.9
12.3
30
45
C03CA01
ATC
furosemide; systemic
2.0
12.3
191
1118
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.1
12.2
47
120
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
12.7
12.2
21
17
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
4.9
12.1
39
83
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
12.1
107
486
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.3
12.0
36
71
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
12.0
163
901
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
11.9
60
192
D07XC01
ATC
betamethasone, combinations; topical
2.5
11.9
96
416
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
11.7
103
466
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
11.6
104
473
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
11.4
64
221
D02AX
ATC
Other emollients and protectives
5.1
11.3
35
72
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
10.9
81
335
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
4.4
10.6
38
91
L03.9
ICD-10 Finland
Cellulitis, unspecified
9.4
10.6
21
23
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.5
10.5
24
33
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
10.5
197
1225
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
10.1
41
111
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
10.1
51
165
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
10.1
99
471
D05BB02
ATC
acitretin; oral
5.4
9.9
29
56
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
8.3
9.9
21
26
NHQ40
NOMESCO Finland
Amputation of toe
8.3
9.9
21
26
D07XB05
ATC
dexamethasone, combinations; topical
5.1
9.8
30
61
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
20.4
9.8
14
7
D11AX14
ATC
[U] tacrolimus; topical
13.6
9.7
16
12
N06AB04
ATC
citalopram; systemic
1.9
9.7
152
884
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.6
268
1880
B18.2
ICD-10 Finland
Chronic viral hepatitis C
9.3
9.6
19
21
L73.2
ICD-10 Finland
Hidradenitis suppurativa
15.3
9.5
15
10
D02AE01
ATC
carbamide; topical
2.8
9.4
59
220
L04AA01
ATC
[U] ciclosporin; systemic
8.2
9.4
20
25
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
6.9
9.2
22
33
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
9.2
89
421
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
9.1
26
49
D11AH01
ATC
tacrolimus; topical
11.7
9.1
16
14
SPAT1254
SPAT
Administration of medicine
2.2
9.1
98
489
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
6.7
9.0
22
34
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
7.6
9.0
20
27
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.4
9.0
43
134
H02AB07
ATC
prednisone; oral
2.1
9.0
103
527
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
8.7
77
349
S18
ICPC
Laceration/cut
1.7
8.7
255
1801
L88
ICD-10 Finland
Pyoderma gangrenosum
50.6
8.7
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
8.7
61
242
N03AX16
ATC
pregabalin; oral
1.9
8.5
149
895
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
8.4
224
1537
N03AX12
ATC
gabapentin; oral
2.1
8.3
100
522
S76
ICPC
Skin infection other
3.2
8.2
41
132
D01AC02
ATC
miconazole; topical
2.5
8.2
65
278
ZZA00
NOMESCO Finland
Split skin graft
4.2
8.1
29
71
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.0
178
1151
J01CF05
ATC
flucloxacillin; systemic
4.3
8.0
28
67
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
7.9
118
669
R60.0
ICD-10 Finland
Localized oedema
2.3
7.9
76
360
R03AC02
ATC
salbutamol; inhalant
1.6
7.9
323
2474
J01AA07
ATC
tetracycline; systemic
2.0
7.8
108
593
SPAT1255
SPAT
Intravenous administration of medicine
2.8
7.8
49
183
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
7.8
113
633
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
6.0
7.7
20
34
D11AX15
ATC
[U] pimecrolimus; topical
45.5
7.7
9
*
D11AH02
ATC
pimecrolimus; topical
45.5
7.7
9
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.4
7.7
36
111
L04AX01
ATC
azathioprine; systemic
3.4
7.7
36
111
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
7.7
82
407
R50.9
ICD-10 Finland
Fever, unspecified
2.0
7.7
96
509
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
25.3
7.6
10
*
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
25.3
7.6
10
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.3
7.6
19
31
N05BA04
ATC
oxazepam; oral
1.8
7.5
158
1005
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.5
236
1681
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
7.5
153
961
E000006
ATC
NA
2.5
7.4
55
228
B00.10
ICD-10 Finland
Herpes simplex facialis
13.5
7.4
12
9
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
7.4
65
293
69240
ICD-8 Finland
Other eczema and dermatitis, Due to other chemicals
+∞
7.3
7
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
7.3
81
408
A02BC02
ATC
pantoprazole; systemic
1.6
7.3
387
3133
69299
ICD-8 Finland
Other eczema and dermatitis, Due to other and unspecified cause
15.9
7.2
11
7
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.5
7.2
24
55
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
7.2
51
207
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
7.2
41
144
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
7.2
112
642
H02AB04
ATC
methylprednisolone; systemic
2.0
7.2
98
537
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
7.2
66
304
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
7.1
172
1138
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
7.1
49
194
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
7.1
169
1114
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.8
7.0
28
76
L28
ICPC
Limited function/disability (L)
2.0
7.0
91
489
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.0
124
744
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.0
85
446
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.6
7.0
29
82
F10.24
ICD-10 Finland
Alcohol depence active use
5.9
7.0
18
31
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
6.9
63
291
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
6.9
85
448
M79.6
ICD-10 Finland
Pain in limb
1.6
6.9
207
1452
J02AC01
ATC
fluconazole; systemic
1.6
6.8
233
1687
SPAT1172
SPAT
Guidance concerning hydration
5.7
6.8
18
32
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.7
6.7
43
163
SPAT1216
SPAT
Assessment of functional ability
1.9
6.6
92
508
N05CD07
ATC
temazepam; oral
2.0
6.6
86
461
M05BA04
ATC
alendronic acid; oral
2.5
6.6
50
211
S87
ICPC
Dermatitis/atopic eczema
4.9
6.6
20
42
N06AB03
ATC
fluoxetine; oral
2.0
6.5
82
436
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
6.5
93
519
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
6.5
45
179
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
7.5
6.4
14
19
134
Kela drug reimbursment
General erythroderma
14.5
6.4
10
7
N05AH04
ATC
quetiapine; oral
1.9
6.4
101
583
SPAT1229
SPAT
Assessment of need for aid
2.3
6.4
54
241
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.1
6.3
23
58
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
6.3
114
689
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
6.3
128
802
N02AA05
ATC
oxycodone; systemic
1.9
6.3
86
473
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
6.3
61
292
A10AE04
ATC
insulin glargine; parenteral
2.2
6.2
63
306
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.2
162
1088
J45
ICD-10 Finland
Asthma
2.2
6.2
63
307
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
6.2
77
407
S10
ICPC
Boil/carbuncle
2.9
6.2
35
123
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
6.1
97
558
D05AX52
ATC
calcipotriol, combinations; topical
2.6
6.1
41
162
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
6.1
41
162
L20
ICD-10 Finland
Atopic dermatitis
3.8
6.1
24
65
N05BA01
ATC
diazepam; systemic, rectal
1.9
6.1
90
507
XQ800
NOMESCO Finland
Prick test
2.4
6.1
49
212
N05BA02
ATC
chlordiazepoxide; systemic
4.0
6.0
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
171
603
3.41
38.94
2.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
270
1441
2.40
26.55
5.4
4.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
155
760
2.32
17.55
2.7
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
357
2466
1.89
15.42
9.6
6.3
mmol/l
1.2
1.2
0.06
321
2228
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
380
2715
1.84
14.40
9.6
6.9
mmol/l
1.2
1.2
0.04
325
2292
(3013115) Eosinophils [#/volume] in Blood
401
2916
1.84
14.32
9.0
6.1
e9/l
0.2
0.2
2.49
339
2572
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
159
854
2.11
14.11
2.3
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
285
1877
1.86
13.91
8.5
5.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
387
2826
1.80
13.22
9.0
5.7
e9/l
0.0
0.0
1.34
330
2455
(3001604) Monocytes [#/volume] in Blood
385
2813
1.79
13.07
8.9
5.7
e9/l
0.6
0.6
1.98
328
2440
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
130
665
2.16
13.01
11.9
6.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
328
2347
1.73
11.48
6.8
4.9
g/l
35.0
35.8
1.50
303
2196
(3019198) Lymphocytes [#/volume] in Blood
385
2883
1.72
11.39
9.2
5.8
e9/l
1.9
1.9
0.15
339
2552
(3013650) Neutrophils [#/volume] in Blood by Automated count
424
3263
1.73
11.32
12.4
9.0
e9/l
4.5
4.0
3.56
361
2866
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
114
584
2.13
11.28
2.1
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
387
2913
1.71
11.14
7.0
6.4
umol/l
10.6
11.9
1.00
371
2754
(3020779) Urea [Moles/volume] in Serum or Plasma
99
486
2.20
10.90
9.4
7.7
mmol/l
8.9
9.2
0.18
94
465
(3000494) Fungus identified in Specimen by Culture
126
683
2.02
10.69
1.7
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
417
3235
1.68
10.44
7.3
4.9
mmol/l
6.9
6.6
1.39
398
3012
(3019069) Monocytes/100 leukocytes in Blood
355
2659
1.66
10.02
10.3
6.1
%
8.4
8.7
0.71
326
2507
(3003458) Phosphate [Moles/volume] in Serum or Plasma
129
722
1.96
9.96
9.4
6.1
mmol/l
1.0
1.0
0.01
123
668
(3002030) Lymphocytes/100 leukocytes in Blood
361
2723
1.65
9.86
9.6
5.9
%
26.4
28.1
2.00
327
2557
(40768443) Skin Pathology biopsy report
56
225
2.61
9.61
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
110
593
2.01
9.43
2.2
1.9
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
111
602
2.00
9.35
8.1
8.4
kpa
11.2
12.2
1.66
104
582
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
111
602
2.00
9.35
8.1
8.4
kpa
5.3
5.1
1.02
102
579
(40761535) Cells panel - Urine sediment
89
445
2.14
9.32
4.5
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
208
1374
1.72
9.31
8.5
6.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
354
2686
1.62
9.23
9.3
5.7
%
58.7
57.0
1.65
324
2534
(3006504) Eosinophils/100 leukocytes in Blood
350
2649
1.62
9.22
9.6
5.8
%
2.9
2.9
0.04
320
2478
(3022096) Basophils/100 leukocytes in Blood
341
2566
1.62
9.18
9.2
5.9
%
0.7
0.7
0.08
311
2407
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
295
2142
1.64
9.18
2.4
1.9
pmol/l
91.8
93.8
0.34
151
1095
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
518
4327
1.70
9.15
9.9
7.4
u/l
77.6
79.1
0.41
491
4073
(3012095) Magnesium [Moles/volume] in Serum or Plasma
148
893
1.83
9.01
4.8
3.8
mmol/l
0.8
0.8
3.39
140
836
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
373
2.19
8.73
1.8
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
109
605
1.94
8.57
8.2
8.4
mmol/l
1.2
1.1
0.02
83
473
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
187
1224
1.71
8.56
1.9
1.9
mg/l
0.9
1.1
1.15
136
941
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
97
517
2.01
8.56
2.6
2.3
g/l
0.2
0.2
0.54
90
481
(3019309) Folate [Moles/volume] in Red Blood Cells
154
958
1.77
8.43
1.8
1.7
nmol/l
1222.6
1189.8
0.15
116
722
(3011397) Hemoglobin [Presence] in Urine by Test strip
190
1263
1.68
8.17
4.5
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
148
918
1.77
8.16
2.9
2.7
e6/l
1.3
0.9
1.16
89
517
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
86
448
2.04
8.07
2.6
2.4
ug/l
4.1
8.4
2.52
72
391
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
58
260
2.34
7.90
7.7
5.8
mmol/l
25.6
24.9
0.62
52
245
(3026008) Bacteria identified in Urine by Culture
225
1577
1.62
7.81
3.5
2.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
21
6.29
7.73
1.0
1.1
iu/ml
322.5
138.9
1.38
13
21
(3032080) INR in Blood by Coagulation assay
293
2192
1.57
7.68
11.4
8.4
inr
1.3
1.2
0.26
69
635
(3022313) Gas panel - Capillary blood
62
290
2.24
7.66
7.3
5.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
228
1613
1.60
7.58
6.7
3.9
ph
7.4
7.4
0.09
42
295
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
76
390
2.06
7.43
7.5
5.0
kpa
5.4
5.1
1.23
69
366
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
297
2248
1.55
7.29
3.0
2.3
nmol/l
72.6
76.2
1.46
259
2016
(3009343) pH of Capillary blood
75
386
2.05
7.27
7.6
5.0
ph
7.4
7.4
—
8
45
(3022217) INR in Platelet poor plasma by Coagulation assay
111
655
1.82
7.18
22.1
20.6
inr
1.3
1.3
0.08
13
96
(3014111) Lactate [Moles/volume] in Serum or Plasma
86
470
1.94
7.05
9.7
7.6
mmol/l
1.3
1.4
0.29
81
447
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72
370
2.05
7.01
7.8
5.1
mmol/l
2.2
1.6
0.55
59
281
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
277
2079
1.54
7.00
4.3
3.5
ng/l
27.7
39.5
1.70
185
1407
(3013707) Erythrocyte sedimentation rate by Westergren method
494
4201
1.56
6.92
5.1
3.9
mm/h
14.5
11.4
3.40
457
3885
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
48
210
2.38
6.92
2.4
1.9
ug/l
2.8
2.9
0.01
41
184
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
269
2013
1.54
6.85
4.4
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1357
1.60
6.84
3.2
2.0
mg/l
3.2
3.0
0.50
160
1158
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
88
3.15
6.80
3.6
4.6
u/ml
629.8
2614.8
—
5
10
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
28
5.08
6.72
1.9
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
226
1637
1.55
6.63
2.5
2.1
u/l
135.0
285.7
1.77
204
1542
(3022948) Iron [Moles/volume] in Serum or Plasma
132
838
1.70
6.62
3.0
2.4
umol/l
11.6
13.6
2.06
116
782
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
238
1747
1.54
6.57
3.4
2.5
u/l
49.7
58.2
4.19
219
1619
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
190
1326
1.59
6.55
2.8
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
66
339
2.04
6.44
4.2
6.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
121
758
1.72
6.35
3.1
2.3
g/l
2.3
2.3
0.04
105
708
(3033658) Prothrombin time (PT) actual/Normal
197
1399
1.56
6.26
5.3
4.1
%
91.3
90.8
0.11
190
1372
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
115
715
1.72
6.20
3.1
2.4
%
20.8
23.6
1.28
96
613
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
97
577
1.79
6.09
5.4
4.6
u/l
224.1
249.0
2.00
91
549
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
61
313
2.04
5.98
1.8
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
250
1889
1.49
5.89
4.1
3.4
u/l
29.6
31.8
0.73
234
1807
(3048689) Calprotectin [Mass/mass] in Stool
108
669
1.72
5.89
2.9
2.4
ug/g
142.0
124.9
0.28
81
541
(3015377) Calcium [Moles/volume] in Serum or Plasma
242
1827
1.49
5.69
3.6
3.4
mmol/l
2.4
2.4
1.07
203
1610
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
164
2.39
5.68
3.3
5.8
u/ml
0.4
0.3
0.31
18
91
(3036481) Cortisol [Moles/volume] in Serum or Plasma
90
537
1.77
5.59
3.1
2.0
nmol/l
364.2
373.9
0.13
83
497
(3017143) Hepatitis C virus Ab [Presence] in Serum
106
665
1.70
5.52
2.0
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
75
425
1.85
5.52
3.8
2.9
e9/l
69.5
70.8
0.12
57
326
(3019225) pH of Specimen
85
503
1.78
5.43
4.4
4.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1527
1.50
5.41
4.1
3.1
ng/l
1557.5
1242.3
0.62
171
1302
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
113
2.63
5.36
5.6
6.7
iu/ml
173.2
424.3
—
5
18
(3044640) Blood type and Crossmatch panel - Blood
231
1749
1.47
5.28
2.9
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
206
1526
1.49
5.25
4.2
3.0
e6/l
1.0
0.5
0.86
156
1134
(3009508) Creatinine [Moles/volume] in Urine
224
1688
1.47
5.24
3.9
3.1
mmol/l
7.9
7.8
0.10
181
1417
(3020891) Body temperature
41
190
2.23
5.23
9.6
4.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
310
2487
1.43
5.19
13.5
9.1
e9/l
0.0
0.0
0.29
251
2048
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
72
411
1.84
5.18
4.8
4.0
ng/l
84.1
79.5
0.16
58
364
(36304419) Bacteria [Presence] in Urine
201
1491
1.48
5.07
4.1
2.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
160
2.32
5.06
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
454
3912
1.43
5.05
5.3
4.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
130
878
1.59
5.05
3.1
2.9
e6/l
3.5
1.9
0.75
72
478
(1761868) Lipid panel - Serum or Plasma
159
2162
0.66
5.01
2.6
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
161
2.30
5.00
1.2
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
76
448
1.78
4.93
14.6
8.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
162
2.29
4.93
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
72
2.97
4.91
1.7
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
504
1.73
4.86
3.2
2.4
u/l
30.0
34.4
0.66
74
431
(3028707) Methadone [Presence] in Urine by Screen method
22
79
2.84
4.75
5.7
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
416
1.78
4.70
1.8
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
206
2.10
4.68
1.9
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
206
1558
1.45
4.65
3.8
3.2
mg/l
1897.2
272.6
1.48
139
1005
(3043409) Potassium [Moles/volume] in Arterial blood
33
147
2.30
4.64
5.8
4.1
mmol/l
3.9
3.9
0.09
33
133
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
122
2.43
4.62
1.4
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
123
837
1.57
4.61
2.7
2.6
s
30.4
29.6
0.65
117
819
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
59
3.10
4.54
1.9
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
52
280
1.92
4.49
10.7
10.1
mmol/l
24.1
24.3
0.13
45
266
(3002032) Base excess in Venous blood by calculation
81
500
1.70
4.48
8.4
4.2
mmol/l
2.8
1.7
2.13
69
393
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
150
2.26
4.43
1.5
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
30
131
2.35
4.42
4.6
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
34
158
2.21
4.34
4.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
54
298
1.88
4.34
1.5
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
193
1459
1.44
4.33
3.9
2.7
umol/l
2405.7
6539.4
1.03
162
1291
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
103
2.48
4.18
1.4
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
223
1.99
4.15
2.3
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
617
5722
1.54
4.04
23.6
13.2
mg/l
27.7
23.5
2.09
528
4479
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
24
4.21
3.90
1.0
1.8
umol/l
67.4
63.9
—
5
16
(3017181) Myelocytes/100 leukocytes in Blood
72
448
1.67
3.88
5.7
4.4
%
0.8
1.0
0.19
30
140
(3027945) Reticulocytes/100 erythrocytes in Blood
88
577
1.60
3.86
3.9
2.7
%
1.8
1.8
0.17
74
524
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
295
1.82
3.86
2.2
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
101
2.42
3.85
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
101
2.42
3.85
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
71
2.72
3.85
1.6
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
41
216
1.95
3.80
1.7
2.1
g/l
1.6
1.5
0.27
35
191
(36660697) Celiac disease serology panel - Serum
70
435
1.67
3.79
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
59
352
1.74
3.71
1.5
1.2
u/ml
2265.5
246.6
1.14
52
320
(3020682) Albumin/Creatinine [Ratio] in Urine
209
1641
1.39
3.71
4.4
3.9
mg/mmol
8.7
9.5
0.11
134
1043
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
36
183
2.02
3.69
2.6
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
483
4315
1.36
3.66
4.3
3.7
pmol/l
14.6
14.7
0.22
437
3927
(3001122) Ferritin [Mass/volume] in Serum or Plasma
295
2453
1.34
3.61
3.3
2.7
ug/l
135.4
120.2
0.37
271
2283
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
14
46
3.08
3.54
1.4
1.1
u/l
50.6
127.7
—
8
31
(3002619) Bacteria identified in Specimen by Culture
8
13
6.21
3.51
1.0
1.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
6
10.07
3.50
1.2
1.0
%
110.3
113.5
—
6
6
(3020630) Protein [Mass/volume] in Serum or Plasma
68
429
1.65
3.49
3.0
3.0
g/l
66.8
66.9
0.03
59
388
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
118
844
1.48
3.49
1.8
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
213
1693
1.37
3.47
4.2
3.1
e6/l
38.7
95.5
0.74
160
1296
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
311
2621
1.33
3.42
4.5
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
38
203
1.92
3.41
1.9
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
218
1.88
3.39
2.4
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
95
2.36
3.36
1.6
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
10
27
3.74
3.36
38.0
25.9
ug/l
6.5
7.4
—
10
22
(3006653) Thiamine [Moles/volume] in Blood
11
32
3.48
3.34
1.5
1.4
nmol/l
150.6
157.3
0.10
11
32
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
83
2.45
3.33
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
243
1982
1.34
3.33
4.8
3.6
e6/l
127.7
96.5
0.13
173
1387
(4010399)
65
412
1.63
3.29
1.5
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
82
550
1.55
3.28
4.5
3.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
28
136
2.10
3.26
1.2
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
32
164
2.00
3.24
3.7
3.8
g/l
4.2
3.5
1.11
32
158
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
67
430
1.62
3.23
3.4
2.6
ml/min/173m2
62.8
67.8
0.32
25
164
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
28
3.61
3.20
1.5
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
165
1281
1.37
3.08
6.5
4.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
65
420
1.60
3.06
6.1
4.5
%
0.1
0.1
0.61
27
128
(3037121) Protein [Mass/volume] in Urine
37
205
1.85
3.00
5.0
3.5
g/l
0.7
0.2
0.59
21
90
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
94
2.27
2.99
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
145
1110
1.38
2.94
1.3
1.5
g/l
2.6
2.5
0.24
79
687
(3002179) Metamyelocytes/100 leukocytes in Blood
63
408
1.60
2.94
5.8
4.2
%
1.3
0.5
0.48
23
102
(3021960) Folate [Moles/volume] in Serum or Plasma
162
1263
1.36
2.94
1.7
1.5
nmol/l
20.0
20.8
0.32
129
1060
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
70
2.46
2.89
4.7
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
291
1.70
2.89
9.5
11.5
—
—
—
0
0
(4198724)
9
22
4.13
2.89
2.8
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
100
720
1.45
2.86
1.8
1.8
%
1.5
1.5
0.38
87
638
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
130
2.04
2.84
2.1
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
325
2808
1.29
2.82
4.4
3.5
estimate
0.0
0.0
0.50
50
507
(3016879) Cocaine [Presence] in Urine
34
188
1.85
2.79
4.4
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
6
8.38
2.75
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
24
119
2.05
2.69
7.2
3.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
65
434
1.55
2.68
2.0
2.8
g/l
10.4
10.4
0.01
55
399
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
160
1262
1.34
2.68
1.3
1.3
u/ml
0.7
1.8
2.08
32
355
(3035350) Ketones [Presence] in Urine by Test strip
320
2772
1.28
2.68
4.4
3.5
estimate
0.0
0.0
0.00
54
519
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
32
3.15
2.65
2.3
3.1
%
95.5
92.5
—
10
32
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
300
1.64
2.60
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
147
1150
1.35
2.60
3.7
2.4
e6/l
9.1
5.7
0.59
126
1007
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
19
87
2.22
2.59
1.5
1.5
u/l
37.6
25.5
0.55
13
73
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
11
38
2.92
2.59
1.0
1.4
—
320.0
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
20
4.03
2.57
1.3
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
7
7.18
2.55
1.4
1.1
umol/l
21.0
16.1
—
5
7
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
30
165
1.85
2.53
4.0
2.8
%
186.9
184.2
0.05
30
159
(3013512) EKG study
193
1578
1.30
2.50
4.2
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
560
5225
1.32
2.49
5.4
4.5
mu/l
1.9
2.1
0.41
512
4779
(40768797) Stomach Pathology biopsy report
102
757
1.40
2.49
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
54
352
1.58
2.48
2.3
2.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
89
2.17
2.46
1.8
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
152
1.88
2.46
2.5
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
175
1.81
2.42
1.7
1.5
iu/ml
0.2
0.0
—
5
32
(3025159) Blasts/100 leukocytes in Blood
59
396
1.53
2.40
6.1
4.5
%
0.2
0.2
0.01
24
110
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
27
3.36
2.40
1.0
1.1
u/l
101.2
802.7
—
9
22
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
118
1.98
2.38
3.7
1.6
nmol/l
0.8
0.8
0.25
17
100
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
8
6.28
2.37
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
8
6.28
2.37
3.4
6.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
52
2.53
2.37
1.2
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
22
3.66
2.37
1.6
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
22
3.66
2.37
1.6
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
17
4.15
2.36
1.1
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
317
2774
1.25
2.35
5.5
4.8
estimate
0.0
0.0
0.00
53
527
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
185
1.76
2.32
2.1
2.1
u/l
17577.3
2873.4
—
10
78
(3004119) Hemoglobin [Mass/volume] in Venous blood
49
318
1.58
2.31
7.5
3.7
g/l
124.9
128.9
0.63
49
311
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
28
3.24
2.31
1.6
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
35
2.88
2.31
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
23
3.51
2.27
1.8
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
128
1.91
2.24
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
428
3888
1.25
2.23
4.5
3.1
u/l
54.0
48.5
0.57
405
3644
(3044927) Protein electrophoresis panel - Urine
13
54
2.43
2.21
1.4
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
125
978
1.34
2.20
3.0
3.0
mmol/l
2.5
2.4
0.35
109
863
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
173
1.77
2.20
1.6
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
22
115
1.94
2.17
1.6
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
33
197
1.71
2.16
4.6
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
55
2.39
2.13
2.3
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
160
1.78
2.12
1.3
1.4
ug/g
190.0
307.8
1.86
15
95
(3027008) Opiates [Presence] in Urine
33
198
1.70
2.12
4.5
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
257
2216
1.25
2.12
2.2
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
23
124
1.88
2.09
2.1
1.6
e6/l
21113.2
11283.8
0.42
17
97
(3028300) Cannabinoids [Presence] in Urine
33
199
1.69
2.09
4.6
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
31
2.93
2.07
3.3
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
185
1.71
2.04
2.1
2.4
g/l
3.2
3.2
0.02
17
147
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
50
2.42
2.03
1.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
50
2.42
2.03
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
50
2.42
2.03
1.9
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
30
178
1.72
2.02
4.1
8.5
mmol/l
1.3
1.3
0.17
25
161
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
31
186
1.70
2.00
1.8
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
118
929
1.32
2.00
1.3
1.3
u/ml
13.5
13.1
0.02
48
362
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
90
683
1.36
1.95
4.5
4.3
%
29.8
31.9
0.81
57
455
(3032057) Clostridioides difficile [Presence] in Stool
5
11
4.57
1.94
2.0
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
27
2.98
1.94
4.0
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
45
2.47
1.93
6.5
2.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
71
2.14
1.93
1.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
39
2.59
1.92
1.6
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
368
0.56
1.91
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
92
1.98
1.91
1.7
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
179
1497
1.26
1.91
5.4
3.7
estimate
0.0
0.0
0.69
52
515
(21494755) Public health laboratory ask at order entry panel
40
596
0.65
1.89
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
553
5213
1.26
1.88
7.1
5.4
mmol/mol
41.2
39.5
3.15
508
4871
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
190
1.66
1.87
1.8
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
28
2.88
1.86
1.4
1.8
—
—
—
0
0
(3000492) Spirometry study
76
566
1.38
1.85
1.4
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
183
1.67
1.84
2.1
2.4
g/l
10.9
10.8
0.03
18
160
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
17
3.55
1.84
1.2
1.4
%
2.5
1.4
—
6
12
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
17
3.55
1.84
1.3
1.4
%
28.8
46.8
—
6
11
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
145
1.75
1.83
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
129
1576
0.78
1.81
3.9
3.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
192
1.64
1.80
1.5
1.3
miu/ml
157.0
249.5
—
9
94
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
200
1.63
1.80
2.0
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
200
1.63
1.80
2.0
2.3
g/l
4.2
3.8
0.78
17
144
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
200
1.63
1.80
2.0
2.3
g/l
7.6
7.4
0.14
17
151
(3019550) Sodium [Moles/volume] in Serum or Plasma
613
5861
1.30
1.80
26.1
15.1
mmol/l
139.2
139.7
4.14
597
5697
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
131
1.78
1.79
1.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
124
1.80
1.77
3.5
3.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
30
2.68
1.72
1.5
3.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
61
2.15
1.72
5.5
2.2
pg
32.0
33.8
0.81
13
61
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
96
1.90
1.72
1.4
1.2
u/ml
7.4
8.8
—
9
44
(3023103) Potassium [Moles/volume] in Serum or Plasma
614
5880
1.30
1.71
26.1
15.2
mmol/l
4.0
4.0
0.24
596
5711
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
82
1.97
1.70
1.8
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
54
385
1.44
1.69
6.1
2.3
e9/l
4.1
4.0
0.08
36
306
(46235355) HIV 1 and 2 tests - Meaningful Use set
129
1055
1.27
1.65
2.2
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
29
182
1.62
1.62
4.1
4.6
%
89.3
89.6
0.02
29
170
(3009466) Valproate [Moles/volume] in Serum or Plasma
15
77
1.97
1.60
4.8
5.1
umol/l
359.5
365.8
0.06
15
66
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
99
1.84
1.58
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
129
1.73
1.58
2.3
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
59
434
1.39
1.57
2.6
3.5
ng/l
185.1
189.5
0.04
50
399
(3042631) Mycobacterium sp identified in Specimen
15
78
1.94
1.55
4.1
2.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
64
2.05
1.55
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
82
638
1.32
1.54
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
138
1.69
1.53
3.0
2.3
ug/min
144.7
122.8
0.11
14
79
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
43
0.00
1.52
0.0
1.4
—
8.1
—
0
36
(3003181) Sodium [Moles/volume] in Urine
16
86
1.88
1.51
5.6
1.3
mmol/l
67.0
63.9
0.06
11
77
(3026782) Osmolality of Urine
132
1095
1.25
1.51
3.7
2.6
mosm/kgh2o
542.8
563.2
0.48
112
926
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
178
1.60
1.51
2.1
2.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
127
0.39
1.51
1.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
317
0.59
1.49
1.7
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
109
1.76
1.48
2.6
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
96
771
1.28
1.43
1.4
1.3
titre
520.0
522.5
0.01
20
161
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.7
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
165
1.60
1.42
1.5
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
561
5350
1.22
1.42
18.1
11.9
ml/min/173m2
84.2
82.5
0.87
465
4393
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
46
2.19
1.40
1.1
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
111
1.73
1.40
13.1
4.1
mmol/l
2.7
2.6
0.13
14
73
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
74
1.91
1.39
1.5
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
198
1.54
1.39
4.9
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
173
1490
1.21
1.39
1.7
1.7
mmol/l
1.5
1.4
1.00
158
1271
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
127
1060
1.24
1.38
5.0
3.6
ng/l
43.6
503.8
4.97
97
807
(40767503) Oxygen content in Capillary blood by calculation
18
104
1.75
1.38
2.2
2.5
%
18.3
16.3
—
8
55
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
80
631
1.30
1.38
3.9
3.0
umol/l
7.0
9.3
0.89
66
559
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.7
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
128
1.66
1.34
1.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
128
1.66
1.34
2.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
335
1.40
1.33
2.1
2.0
—
—
—
0
0
(3036489) Thrombin time
31
209
1.50
1.32
3.4
3.0
s
22.1
21.6
0.22
26
191
(3028026) IgM [Mass/volume] in Serum or Plasma
47
344
1.39
1.32
1.7
1.6
g/l
0.9
1.6
2.35
42
321
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
24
2.51
1.30
2.5
2.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
8
34
2.37
1.29
5.8
20.1
nmol/l
993.3
1459.6
—
8
34
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
18
2.79
1.28
1.2
2.5
%
208.6
124.3
—
5
18
(3000093) Morphology [Interpretation] in Blood Narrative
9
45
2.01
1.23
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
63
1.92
1.23
1.7
1.2
—
—
—
0
0
(4146454)
11
56
1.98
1.22
2.6
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
56
1.98
1.22
1.5
1.9
—
—
—
0
0
(4035726)
60
463
1.32
1.22
1.5
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
49
2.06
1.22
1.4
1.6
promille
1.9
1.2
—
5
42
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
137
1594
0.83
1.22
4.7
4.1
%
20.4
20.8
0.13
60
742
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
124
1.63
1.22
2.1
1.4
u/ml
254.1
253.3
0.00
13
74
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
8
37
2.17
1.21
1.8
2.2
—
149.0
—
0
5
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
53
402
1.34
1.21
2.5
2.4
—
17.7
—
0
22
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
125
1057
1.22
1.21
1.7
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
71
1.85
1.20
2.2
1.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
50
2.01
1.17
1.6
1.1
nmol/l
1.1
1.5
—
10
45
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
39
2.06
1.15
1.3
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
20
2.51
1.15
1.0
1.1
miu/ml
1656.6
1581.1
—
5
20
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
549
0.73
1.15
1.5
1.7
—
—
—
0
0
(4268621)
12
65
1.86
1.14
2.3
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
151
1.54
1.13
3.3
3.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
66
523
1.29
1.13
3.5
4.4
ug/l
8.3
36.6
1.02
49
431
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
97
1158
0.81
1.12
3.2
3.0
ug/l
0.6
0.8
1.94
62
748
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
260
1.40
1.12
2.1
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
66
1.83
1.09
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
21
2.39
1.09
1.0
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.9
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
33
2.13
1.05
2.3
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
67
1.80
1.05
2.3
1.7
—
—
—
0
0
(4094501)
8
150
0.53
1.04
1.3
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
22
2.28
1.03
2.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
22
2.28
1.03
6.8
5.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
34
2.07
1.03
5.3
12.7
nmol/l
559.1
813.4
—
7
34
(3011648) Oxygen content in Venous blood
9
48
1.89
1.00
1.8
4.9
%
12.1
11.3
—
9
48
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
23
156
1.49
0.99
1.3
2.5
g/l
37.2
38.0
0.21
15
137
(3019150) Specific gravity of Urine by Refractometry
142
1240
1.18
0.99
5.8
3.7
kg/l
1.0
1.0
0.56
18
176
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
174
0.57
0.97
1.6
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
8.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
108
1.59
0.97
1.9
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
418
3950
1.14
0.96
4.1
3.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
3.3
2.2
umol/l
56.8
47.1
—
6
20
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.7
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
24
168
1.44
0.90
2.1
2.6
g/l
0.3
1.2
1.31
16
151
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
21
144
1.47
0.88
1.4
1.2
u/ml
3.4
13.4
—
6
24
(3045142) Bone marrow Pathology biopsy report
10
56
1.80
0.88
2.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
43
1.87
0.87
1.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
72
1.68
0.85
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
6
31
1.94
0.84
1.0
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
618
6022
1.18
0.84
20.3
12.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
65
1.70
0.82
1.5
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
81
1.62
0.81
1.8
2.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
625
6101
1.18
0.80
15.0
10.0
u/l
27.2
26.9
0.14
604
5897
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
106
1.52
0.79
3.4
3.4
e9/l
3.2
4.2
1.64
16
106
(3037556) Urate [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
48
1.67
0.79
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
90
1.57
0.78
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
107
1.51
0.76
4.1
3.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
53
1.71
0.75
1.0
1.6
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
24
2.09
0.74
1.4
2.2
nmol/l
13.7
10.1
—
5
18
(3006462) Nitrate [Presence] in Urine
5
24
2.09
0.74
4.0
3.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
55
1.64
0.73
2.1
1.2
—
—
—
0
0
(4211845)
5
26
1.93
0.70
4.0
3.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
26
1.93
0.70
6.6
4.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
251
0.71
0.70
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
143
0.62
0.70
4.2
4.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
42
1.67
0.68
1.4
3.0
e9/l
0.2
0.2
—
7
34
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
110
973
1.15
0.68
1.4
1.3
iu/ml
42.2
34.7
0.21
31
300
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
94
1.50
0.67
8.7
3.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
111
1.45
0.66
3.8
3.6
%
52.1
57.3
0.73
16
111
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
1.6
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
29
1.73
0.64
1.0
1.1
—
1.1
—
0
11
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
112
1.44
0.64
1.0
1.6
—
—
—
0
0
(4306422)
13
87
1.50
0.63
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
63
536
1.19
0.63
1.6
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
49
1.64
0.62
1.3
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.3
ug/l
6.5
7.0
—
5
25
(3017704) Immunofixation for Urine
5
30
1.67
0.61
1.8
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
139
1.38
0.61
1.2
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
64
1.57
0.59
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
53
1.52
0.58
1.4
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
115
0.60
0.58
1.9
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
181
1955
0.90
0.58
4.7
4.8
ug/l
2.5
2.7
0.15
153
1766
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
14.7
10.5
mmol/l
0.6
0.6
—
6
35
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
1.2
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
12
81
1.49
0.57
1.3
1.2
u/l
18.7
17.7
0.05
12
71
(4027681)
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
150
1.34
0.56
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
60
1.51
0.54
2.7
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
146
0.68
0.52
1.6
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
63
1.43
0.52
1.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
126
1.36
0.52
1.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
149
1614
0.90
0.51
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
67
1.50
0.50
2.3
2.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
544
5311
1.10
0.50
22.3
14.2
%
38.8
40.1
2.32
355
3930
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
101
1.39
0.50
1.2
1.1
u/ml
3.7
2.9
—
8
39
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
1.9
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
21
266
0.78
0.47
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
68
1.48
0.47
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
68
1.48
0.47
1.1
1.0
u/ml
1.9
4.3
—
5
21
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
200
1.26
0.47
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
79
705
1.14
0.46
1.3
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
118
0.67
0.46
1.8
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.4
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
382
3684
1.08
0.45
3.3
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
50
1.40
0.45
2.6
3.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
56
1.43
0.42
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
34
286
1.20
0.42
1.1
1.1
—
137.1
—
0
10
(3003338) MCHC [Mass/volume]
482
4939
0.93
0.41
29.2
16.9
g/l
331.1
333.0
4.75
477
4902
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
138
0.72
0.40
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
138
0.72
0.40
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
138
0.72
0.40
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
138
0.72
0.40
1.6
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
68
1.33
0.37
1.4
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
115
0.69
0.37
1.8
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
202
0.79
0.37
2.2
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
552
5421
1.08
0.35
4.6
3.8
mmol/l
1.4
1.3
1.75
501
5001
(40768800) Prostate Pathology biopsy report
9
125
0.72
0.35
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
30
257
1.17
0.32
3.2
3.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
47
1.28
0.32
2.3
2.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
84
1.31
0.30
1.2
1.0
u/ml
0.6
5.7
—
5
19
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
569
5609
1.07
0.28
5.0
4.2
mmol/l
1.4
1.5
4.19
516
5191
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
581
5733
1.07
0.28
5.5
4.7
mmol/l
2.6
2.8
4.34
530
5302
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
73
673
1.09
0.27
2.2
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
64
1.25
0.27
1.1
1.4
nmol/l
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
655
0.91
0.27
1.8
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
86
1.28
0.26
1.1
1.0
u/ml
0.6
6.7
—
5
40
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
86
1.28
0.26
4.2
2.2
u/ml
514.5
193.4
0.25
11
80
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
73
0.68
0.26
26.6
1.9
%
13.2
13.2
—
5
73
(44790048)
9
73
1.24
0.25
2.9
1.9
—
—
—
0
0
(44790047)
9
73
1.24
0.25
2.9
1.9
—
—
—
0
0
(44806118)
9
73
1.24
0.25
2.9
1.9
—
—
—
0
0
(44790049)
9
73
1.24
0.25
2.9
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
73
1.24
0.25
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
571
5639
1.06
0.24
5.1
4.3
mmol/l
4.4
4.7
5.79
520
5249
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
256
1.14
0.23
1.6
1.3
iu/l
32.8
28.4
0.29
24
215
(3022621) pH of Urine by Test strip
39
352
1.11
0.23
3.2
2.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
39
1.28
0.23
1.4
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
91
856
1.07
0.23
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
66
613
1.08
0.22
2.2
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
125
1.20
0.22
1.9
2.2
g/l
143.3
131.6
—
9
94
(44813793)
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
5
42
1.19
0.21
1.6
1.6
—
1965.5
—
0
8
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
154
1.17
0.21
1.4
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
558
5516
1.05
0.20
5.5
4.3
mmol/l
6.2
5.9
3.35
509
5051
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
80
1.25
0.20
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
80
1.25
0.20
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
80
1.25
0.20
1.4
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.0
—
15.8
—
0
9
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
14
0.00
0.20
0.0
1.7
—
8.4
—
0
8
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
24.2
—
0
14
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
111
0.81
0.20
1.9
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
90
1.23
0.19
2.4
1.8
—
—
—
0
0
(4062490)
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
81
1.24
0.19
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
82
1.22
0.17
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
82
1.22
0.17
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
66
0.76
0.17
1.0
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
67
0.74
0.17
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
19
167
1.14
0.17
1.8
1.4
u/l
10.6
9.9
0.05
14
135
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
263
1.11
0.16
3.0
2.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
70
1.14
0.16
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
293
1.10
0.15
1.1
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
371
1.08
0.15
1.3
1.2
—
—
—
0
0
(4034850)
15
171
0.87
0.15
18.8
9.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
90
0.78
0.14
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
117
1129
1.04
0.14
1.5
1.7
pmol/l
479.8
18346136.4
1.04
96
943
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
223
2180
1.03
0.14
4.9
3.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
96
0.83
0.14
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
110
0.82
0.13
1.3
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
85
1.18
0.12
2.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
46
487
0.94
0.12
5.3
3.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
126
0.87
0.11
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
39
413
0.94
0.10
1.4
1.2
iu/ml
43.0
162.1
4.79
15
168
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
26
241
1.08
0.10
1.0
2.0
u/l
39.3
39.5
0.01
20
217
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
232
1.08
0.10
1.4
1.7
mg/l
2.4
2.9
0.21
16
169
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
55
1.09
0.09
1.3
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
55
1.09
0.09
1.2
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
62
0.81
0.08
1.4
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
67
1.05
0.08
4.0
3.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
225
1.07
0.07
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
84
0.83
0.07
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
95
0.84
0.06
2.9
3.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
169
1.07
0.05
1.1
1.1
—
9.0
—
0
24
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
169
0.95
0.03
1.0
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
460
1.02
0.02
2.6
2.1
nmol/l
12.5
13.2
0.25
42
411
(3000963) Hemoglobin [Mass/volume] in Blood
642
6428
0.99
0.01
33.8
19.5
g/l
132.5
136.1
7.34
631
6331
(3010813) Leukocytes [#/volume] in Blood
642
6427
0.99
0.01
33.3
19.4
e9/l
7.2
6.7
6.26
623
6233
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
154
1.04
0.00
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
574
1.01
0.00
1.4
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
642
6426
0.99
0.00
33.3
19.3
e12/l
4.4
4.5
4.84
625
6237
(3002523) Influenza virus A Ag [Presence] in Specimen
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
642
6425
0.99
0.00
33.2
19.2
pg
30.1
30.3
1.72
630
6328
(3024731) MCV [Entitic volume]
642
6424
0.99
0.00
33.2
19.3
fl
90.9
90.9
0.07
630
6329
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
101
0.99
0.00
1.0
1.1
—
12.0
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
139
1.01
0.00
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
642
6422
1.00
0.00
33.2
19.4
e9/l
256.9
249.1
1.88
625
6251
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.6
—
0.3
—
0
8
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
13.7
—
0
7
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
1.0
—
85.6
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
77.2
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
69
1.01
0.00
22.7
6.4
mmol/l
8.5
7.0
—
7
57
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
50
1.00
0.00
1.6
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
77
0.91
0.00
1.4
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
78
0.90
0.00
1.3
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
59
1.02
0.00
3.3
2.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
1.8
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint L12_PYODERMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PYODERMA | 2.971 [2.44, 3.62] | < 0.001 |
| Birth year | 0.996 [0.99, 1.01] | 0.409 |
During the follow-up period (1.1.1998 — 31.12.2019), 506 out of 2065 females with L12_PYODERMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PYODERMA | 3.025 [2.54, 3.61] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 688 out of 2431 males with L12_PYODERMA died.
Mortality risk
Mortality risk for people of age
years, who have L12_PYODERMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.308% | 0.658% |
| 5 | 1.762% | 3.384% |
| 10 | 4.729% | 8.653% |
| 15 | 8.484% | 16.462% |
| 20 | 14.789% | 26.195% |
Relationships between endpoints
↥Index endpoint: L12_PYODERMA – Pyoderma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data